The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40
Open accessAbstract
The mechanistic target of rapamycin complex 1 (mTORC1) controls cell growth and metabolism in response to nutrients, energy levels, and growth factors. It contains the atypical kinase mTOR and the RAPTOR subunit that binds to the Tor signalling sequence (TOS) motif of substrates and regulators. mTORC1 is activated by the small GTPase RHEB (Ras homologue enriched in brain) and inhibited by PRAS40. Here we present the 3.0 ångström cryo-electron microscopy structure of mTORC1 and the 3.4 ångström structure of activated RHEB-mTORC1. RHEB binds to mTOR distally from the kinase active site, yet causes a global conformational change that allosterically realigns active-site residues, accelerating catalysis. Cancer-associated hyperactivating mutations map to structural elements that maintain the inactive state, and we provide biochemical evidence that they mimic RHEB relieving auto-inhibition. We also present crystal structures of RAPTOR-TOS motif complexes that define the determinants of TOS recognition, of an mTOR FKBP12-rapamycin-binding (FRB) domain-substrate complex that establishes a second substrate-recruitment mechanism, and of a truncated mTOR-PRAS40 complex that reveals PRAS40 inhibits both substrate-recruitment sites. These findings help explain how mTORC1 selects its substrates, how its kinase activity is controlled, and how it is activated by cancer-associated mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High resolution structures of mTORC1 have provided a previously unprecedented look at how mTORC1 is activated by nutrients and how it is inhibited by rapamycin 155–157.”
From Targeting the biology of aging with mTOR inhibitors (2023) · cites this paper as [157]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Cryo-electron microscopy has revealed that Rheb-GTP binds allosterically to mTOR, resulting in a global conformational change that allosterically realigns the active-site residues to enable substrate phosphorylation 157.”
From Targeting the biology of aging with mTOR inhibitors (2023) · cites this paper as [157]
In the citing paper
“Cross-linking of mTORC1 in the presence of RhebGTPgS and 4EBP1, another well-known mTORC1 substrate (Burnett et al., 1998), yielded the cryo-EM structure of mTORC1 bound to Rheb (Yang et al., 2017).”
From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as Yang et al., 2017
In the citing paper
“Density corresponding to Rheb was observed at the N-terminal portions of the N- HEAT, M-HEAT and FAT domains, thereby resulting in a four-way interface where Rheb switch I residues bound the M-HEAT solenoid and FAT domain, and switch II formed contacts with all three mTORC1 domains.”
From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as Yang et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,882
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Jones, T. A., Zou, J.-Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,616
Overview of the CCP 4 suite and current developments
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910045749 · Cited by 12,353
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E. J., Armache, J., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,496
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkòczi, G., Chen, V. B., Davis, I., Echols, N., Headd, J. J., Hung, L., Kapral, G. J., Grosse‐Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Electrostatics of nanosystems: Application to microtubules and the ribosome
Baker, N., Sept, D., Joseph, S., Holst, M., & McCammon, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181342398 · Cited by 7,125
RELION: Implementation of a Bayesian approach to cryo-EM structure determination
Scheres, S. H. W. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.09.006 · Cited by 5,446
Cited by
Sorted by citations
mTOR at the nexus of nutrition, growth, ageing and disease
Liu, G. Y., & Sabatini, D. M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0199-y · Cited by 2,737
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Glaviano, A., Foo, A. S. C., Lam, H. Y., Yap, K. C. H., Jacot, W., Jones, R. H., Eng, H., Nair, M. G., Makvandi, P., Geoerger, B., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01827-6 · Cited by 2,138
mTOR signalling and cellular metabolism are mutual determinants in cancer
Mossmann, D., Park, S., & Hall, M. N. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0074-8 · Cited by 1,088
mTOR as a central hub of nutrient signalling and cell growth
Kim, J., & Guan, K. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0205-1 · Cited by 1,094
The lysosome as a cellular centre for signalling, metabolism and quality control
Lawrence, R. E., & Zoncu, R. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0244-7 · Cited by 920
Regulation and metabolic functions of mTORC1 and mTORC2
Szwed, A., Kim, E., & Jacinto, E. (2021) · Physiological Reviews · doi:10.1152/physrev.00026.2020 · Cited by 848
AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control
González, A., Hall, M. N., Lin, S.-C., & Hardie, D. G. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.015 · Cited by 797
Molecular mechanisms of dietary restriction promoting health and longevity
Green, C. L., Lamming, D. W., & Fontana, L. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00411-4 · Cited by 714
mTOR: Role in cancer, metastasis and drug resistance
Murugan, A. K. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.003 · Cited by 483
mTOR as a central regulator of lifespan and aging
Papadopoli, D. J., Boulay, K., Kazak, L., Pollak, M., Mallette, F. A., Topisirović, I., & Hulea, L. (2019) · F1000Research · doi:10.12688/f1000research.17196.1 · Cited by 443
mTOR substrate phosphorylation in growth control
Battaglioni, S., Benjamin, D., Wälchli, M., Maier, T., & Hall, M. N. (2022) · Cell · doi:10.1016/j.cell.2022.04.013 · Cited by 443
Targeting the biology of aging with mTOR inhibitors
Mannick, J. B., & Lamming, D. W. (2023) · Nature Aging · doi:10.1038/s43587-023-00416-y · Cited by 372
Autophagy and Autophagy-Related Diseases: A Review
Ichimiya, T., Yamakawa, T., Hirano, T., Yokoyama, Y., Hayashi, Y., Hirayama, D., Wagatsuma, K., Itoi, T., & Nakase, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238974 · Cited by 358
A substrate-specific mTORC1 pathway underlies Birt–Hogg–Dubé syndrome
Napolitano, G., Di Malta, C., Esposito, A., de Araujo, M. E. G., Pece, S., Bertalot, G., Matarese, M., Benedetti, V., Zampelli, A., Stasyk, T., et al. (2020) · Nature · doi:10.1038/s41586-020-2444-0 · Cited by 341
Signaling Pathways Involved in the Regulation of mRNA Translation
Roux, P. P., & Topisirović, I. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00070-18 · Cited by 332
Molecular logic of mTORC1 signalling as a metabolic rheostat
Valvezan, A. J., & Manning, B. D. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0038-7 · Cited by 305
Amino acid-dependent control of mTORC1 signaling: a variety of regulatory modes
Takahara, T., Amemiya, Y., Sugiyama, R., Maki, M., & Shibata, H. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00679-2 · Cited by 300
Cellular functions of the protein kinase ATM and their relevance to human disease
Lee, J., & Paull, T. T. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00394-2 · Cited by 303
Goul, C., Peruzzo, R., & Zoncu, R. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00641-8 · Cited by 280
Capturing the phosphorylation and protein interaction landscape of the plant TOR kinase
Leene, J. V., Han, C., Gadeyne, A., Eeckhout, D., Matthijs, C., Cannoot, B., Winne, N. D., Persiau, G., Slijke, E. V. D., van de Cotte, B., et al. (2019) · Nature Plants · doi:10.1038/s41477-019-0378-z · Cited by 269
Jhanwar-Uniyal, M., Wainwright, J. V., Mohan, A. L., Tobias, M. E., Murali, R., Gandhi, C. D., & Schmidt, M. H. (2019) · Advances in Biological Regulation · doi:10.1016/j.jbior.2019.03.003 · Cited by 268
Li, L., Liu, X., Sanders, K. L., Edwards, J. L., Ye, J., Si, F., Gao, A., Huang, L., Hsueh, E. C., Ford, D. A., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.020 · Cited by 248
Glutamine and asparagine activate mTORC1 independently of Rag GTPases
Meng, D., Yang, Q., Wang, H., Melick, C. H., Navlani, R., Frank, A. R., & Jewell, J. L. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ac119.011578 · Cited by 242
Targeting mTOR and Metabolism in Cancer: Lessons and Innovations
Magaway, C., Kim, E., & Jacinto, E. (2019) · Cells · doi:10.3390/cells8121584 · Cited by 230
AMPK directly activates mTORC2 to promote cell survival during acute energetic stress
Kazyken, D., Magnuson, B., Bodur, Ç., Acosta-Jaquez, H. A., Zhang, D., Tong, X., Barnes, T. M., Steinl, G. K., Patterson, N., Altheim, C. H., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aav3249 · Cited by 226
Structural basis for the docking of mTORC1 on the lysosomal surface
Rogala, K. B., Gu, X., Kedir, J. F., Abu-Remaileh, M., Bianchi, L. F., Bottino, A. M. S., Dueholm, R., Niehaus, A., Overwijn, D., Fils, A.-C. P., et al. (2019) · Science · doi:10.1126/science.aay0166 · Cited by 214
Structure of the lysosomal mTORC1–TFEB–Rag–Ragulator megacomplex
Cui, Z., Napolitano, G., de Araújo, M. E. G., Esposito, A., Monfregola, J., Huber, L. A., Ballabio, A., & Hurley, J. H. (2023) · Nature · doi:10.1038/s41586-022-05652-7 · Cited by 205
Lysosome: The metabolic signaling hub
Lamming, D. W., & Bar‐Peled, L. (2019) · Traffic · doi:10.1111/tra.12617 · Cited by 173
mTORC1 and Nutrient Homeostasis: The Central Role of the Lysosome
Rabanal‐Ruiz, Y., & Korolchuk, V. I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030818 · Cited by 178
Regulation of Body Size and Growth Control
Texada, M. J., Koyama, T., & Rewitz, K. (2020) · Genetics · doi:10.1534/genetics.120.303095 · Cited by 177
The role of lysosomes in cancer development and progression
Tang, T., Yang, Z., Wang, D., Yang, X., Wang, J., Li, L., Wen, Q., Gao, L., Bian, X., & Yu, S. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00489-x · Cited by 173
The central moTOR of metabolism
Simcox, J., & Lamming, D. W. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.02.024 · Cited by 174
Structural basis of homologous recombination
Sun, Y., McCorvie, T. J., Yates, L. A., & Zhang, X. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03365-1 · Cited by 175
Metabolic reprogramming, sensing, and cancer therapy
Mao, Y., Xia, Z., Xia, W., & Jiang, P. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115064 · Cited by 180
The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2
Kovalski, J. R., Bhaduri, A., Zehnder, A. M., Neela, P. H., Che, Y., Wozniak, G. G., & Khavari, P. A. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.12.001 · Cited by 154
Architecture of human Rag GTPase heterodimers and their complex with mTORC1
Anandapadamanaban, M., Masson, G. R., Perisic, O., Berndt, A., Kaufman, J., Johnson, C. M., Santhanam, B., Rogala, K. B., Sabatini, D. M., & Williams, R. L. (2019) · Science · doi:10.1126/science.aax3939 · Cited by 147
A small-molecule PI3Kα activator for cardioprotection and neuroregeneration
Gong, G. Q., Bilanges, B., Allsop, B., Masson, G. R., Roberton, V. H., Askwith, T., Oxenford, S. J., Madsen, R. R., Conduit, S. E., Bellini, D., et al. (2023) · Nature · doi:10.1038/s41586-023-05972-2 · Cited by 155
A multi-omic single-cell landscape of human gynecologic malignancies
Regner, M. J., Wiśniewska, K., García‐Recio, S., Thennavan, A., Méndez-Giráldez, R., Malladi, V. S., Hawkins, G. M., Parker, J. S., Perou, C. M., Bae-Jump, V. L., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.10.013 · Cited by 144
Non-canonical mTORC1 signaling at the lysosome
Napolitano, G., Malta, C. D., & Ballabio, A. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.04.012 · Cited by 139
How Lysosomes Sense, Integrate, and Cope with Stress
Säftig, P., & Puertollano, R. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.09.004 · Cited by 139
Roles of mTOR Signaling in Tissue Regeneration
Wei, X., Luo, L., & Chen, J.-Z. (2019) · Cells · doi:10.3390/cells8091075 · Cited by 135
Cryo-EM Structure of the Human FLCN-FNIP2-Rag-Ragulator Complex
Shen, K., Rogala, K. B., Chou, H., Huang, R. K., Yu, Z., & Sabatini, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.10.036 · Cited by 135
Cryo-EM structure of human mTOR complex 2
Chen, X., Liu, M., Tian, Y., Li, J., Qi, Y., Zhao, D., Wu, Z., Huang, M., Wong, C. C. L., Wang, H., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0029-3 · Cited by 138
Self-citationStructure of an activated DNA-PK and its implications for NHEJ
Chen, X., Xu, X., Chen, Y., Cheung, J., Wang, H., Jiang, J., de Val, N., Fox, T. L., Gellert, M. F., & Yang, W. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.12.015 · Cited by 127
Spatially Distinct Pools of TORC1 Balance Protein Homeostasis
Hatakeyama, R., Gulli, M., Hu, Z., Jaquenoud, M., Osuna, G. M. G., Sardu, A., Dengjel, J., & VIRGILIO, C. D. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.10.040 · Cited by 128
Eukaryotic translation initiation factors as promising targets in cancer therapy
Hao, P., Yu, J., Ward, R. J., Liu, Y., Qiao, H., An, S., & Xu, T. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00607-9 · Cited by 127
The Lysosome at the Intersection of Cellular Growth and Destruction
Shin, H. R., & Zoncu, R. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.010 · Cited by 119
The dynamic mechanism of 4E-BP1 recognition and phosphorylation by mTORC1
Böhm, R., Imseng, S., Jakob, R. P., Hall, M. N., Maier, T., & Hiller, S. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.031 · Cited by 111
The 3.2-Å resolution structure of human mTORC2
Scaiola, A., Mangia, F., Imseng, S., Boehringer, D., Berneiser, K., Shimobayashi, M., Stuttfeld, E., Hall, M. N., Ban, N., & Maier, T. (2020) · Science Advances · doi:10.1126/sciadv.abc1251 · Cited by 105
Lawrence, R. E., Cho, K. F., Rappold, R., Thrun, A., Tofaute, M. J., Kim, D. J., Moldavski, O., Hurley, J. H., & Zoncu, R. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0148-6 · Cited by 107
Guo, Y., Zhu, X., Zeng, M., Qi, L., Tang, X., Wang, D., Zhang, M., Xie, Y., Li, H., Yang, X., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01443-2 · Cited by 105
Regulation of mTORC1 by Upstream Stimuli
Melick, C. H., & Jewell, J. L. (2020) · Genes · doi:10.3390/genes11090989 · Cited by 103
mTOR signaling and Alzheimer's disease: What we know and where we are?
Davoody, S., Asgari Taei, A., Khodabakhsh, P., & Dargahi, L. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14463 · Cited by 96
Gillingham, A. K., Bertram, J., Begum, F., & Munro, S. (2019) · eLife · doi:10.7554/elife.45916 · Cited by 95
A small molecule inhibitor of Rheb selectively targets mTORC1 signaling
Mahoney, S. J., Narayan, S., Molz, L., Berstler, L. A., Kang, S. A., Vlasuk, G. P., & Saiah, E. (2018) · Nature Communications · doi:10.1038/s41467-018-03035-z · Cited by 88
Mitochondrial and metabolic alterations in cancer cells
Gregorio, J. D., Petricca, S., Iorio, R., Toniato, E., & Flati, V. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151225 · Cited by 95
Searching for the link between inflammaging and sarcopenia
Wang, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101611 · Cited by 90
New insights into no-go, non-stop and nonsense-mediated mRNA decay complexes
Powers, K. T., Szeto, J.-Y. A., & Schaffitzel, C. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.06.011 · Cited by 84
mTOR in programmed cell death and its therapeutic implications
Xie, Y., Lei, X., Zhao, G., Guo, R., & Cui, N. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.06.002 · Cited by 83
Mutvei, A. P., Nagiec, M. J., Hamann, J. C., Kim, S. G., Vincent, C. T., & Blenis, J. (2020) · Nature Communications · doi:10.1038/s41467-020-15156-5 · Cited by 82
Autophosphorylation transforms DNA-PK from protecting to processing DNA ends
Liu, L., Chen, X., Li, J., Wang, H., Buehl, C. J., Goff, N. J., Meek, K., Yang, W., & Gellert, M. F. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.11.025 · Cited by 80
Structural and functional analysis of the role of the chaperonin CCT in mTOR complex assembly
Cuéllar, J., Ludlam, W. G., Tensmeyer, N. C., Aoba, T., Dhavale, M., Santiago, C. A., Bueno-Carrasco, M. T., Mann, M. J., Plimpton, R. L., Makaju, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10781-1 · Cited by 78
The post‐translational regulation of transcription factor EB (TFEB) in health and disease
Takla, M., Keshri, S., & Rubinsztein, D. C. (2023) · EMBO Reports · doi:10.15252/embr.202357574 · Cited by 77
Burnett, G. L., Yang, Y. C., Aggen, J. B., Pitzen, J., Gliedt, M. K., Semko, C. M., Marquez, A., Evans, J. W., Wang, G., Won, W. S., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01658 · Cited by 72
Critical role of mTOR in regulating aerobic glycolysis in carcinogenesis (Review)
Fan, H. J., Wu, Y., Yu, S., Li, X., Wang, A., Wang, S., Chen, W., & Lu, Y. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5152 · Cited by 72
Trautman, M. E., Richardson, N. E., & Lamming, D. W. (2022) · Aging Cell · doi:10.1111/acel.13626 · Cited by 68
The tRNA-GCN2-FBXO22-axis-mediated mTOR ubiquitination senses amino acid insufficiency
Ge, M.-K., Zhang, C., Zhang, N., He, P., Cai, H., Li, S., Wu, S., Chu, X., Zhang, Y., Ma, H., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.016 · Cited by 73
Weak membrane interactions allow Rheb to activate mTORC1 signaling without major lysosome enrichment
Angarola, B. L., & Ferguson, S. M. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e19-03-0146 · Cited by 67
Evolutionarily divergent mTOR remodels translatome for tissue regeneration
Zhulyn, O., Rosenblatt, H. D., Shokat, L., Dai, S. A., Kuzuoğlu‐Öztürk, D., Zhang, Z., Ruggero, D., Shokat, K. M., & Barna, M. (2023) · Nature · doi:10.1038/s41586-023-06365-1 · Cited by 73
Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney
Kapur, P., Gao, M., Zhong, H., Chintalapati, S., Mitui, M., Barnes, S. D., Zhou, Q., Miyata, J., Carrillo, D., Malladi, V. S., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00896-6 · Cited by 65
Regulation of mTOR by phosphatidic acid
Frias, M. A., Hatipoglu, A., & Foster, D. A. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.01.004 · Cited by 62
Autophagy Function and Dysfunction: Potential Drugs as Anti-Cancer Therapy
Cuomo, F., Altucci, L., & Cobellis, G. (2019) · Cancers · doi:10.3390/cancers11101465 · Cited by 64
The complex network of mTOR signalling in the heart
Sciarretta, S., Forte, M., Frati, G., & Sadoshima, J. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab033 · Cited by 66
Snf1/AMPK fine-tunes TORC1 signaling in response to glucose starvation
Caligaris, M., Nicastro, R., Hu, Z., Tripodi, F., Hummel, J. E., Pillet, B., Deprez, M.-A., Winderickx, J., Rospert, S., Coccetti, P., et al. (2023) · eLife · doi:10.7554/elife.84319 · Cited by 61
TSC1 binding to lysosomal PIPs is required for TSC complex translocation and mTORC1 regulation
Fitzian, K., Brückner, A., Brohée, L., Zech, R., Antoni, C., Kiontke, S., Gasper, R., Matos, A. L. L., Beel, S., Wilhelm, S., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.04.019 · Cited by 57
Architecture and activation of phosphatidylinositol 3-kinase related kinases
Imseng, S., Aylett, C. H. S., & Maier, T. (2018) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.03.010 · Cited by 62
Signal Transduction: Magnesium Manifests as a Second Messenger
Stangherlin, A., & O'Neill, J. S. (2018) · Current Biology · doi:10.1016/j.cub.2018.11.003 · Cited by 59
Phospholipase D as a key modulator of cancer progression
Yao, Y., Wang, X., Li, H., Fan, J., Qian, X., Li, H., & Xu, Y. (2020) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12592 · Cited by 60
Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease
Benn, C., & Dawson, L. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00242 · Cited by 59
Mitochondrial-encoded MOTS-c prevents pancreatic islet destruction in autoimmune diabetes
Kong, B. S., Min, S. H., Lee, C. D., & Cho, Y. M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109447 · Cited by 69
TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex
Alesi, N., Khabibullin, D., Rosenthal, D. M., Akl, E. W., Cory, P. M., Alchoueiry, M., Salem, S., Daou, M., Gibbons, W. F., Chen, J. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44229-4 · Cited by 61
Structure of the human ATM kinase and mechanism of Nbs1 binding
Warren, C., & Pavletich, N. P. (2022) · eLife · doi:10.7554/elife.74218 · Cited by 57
Self-citationResistance Exercise-Induced Hypertrophy: A Potential Role for Rapamycin-Insensitive mTOR
Ogasawara, R., Jensen, T. E., Goodman, C. A., & Hornberger, T. A. (2019) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000189 · Cited by 58
Regulation of mTORC1 by Small GTPases in Response to Nutrients
Zhu, M., & Wang, X. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz301 · Cited by 55
Next Generation Strategies for Geroprotection via mTORC1 Inhibition
Dumas, S. N., & Lamming, D. W. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz056 · Cited by 53
Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143798 · Cited by 57
mTOR Signaling in Metabolic Stress Adaptation
Wu, C., & Storey, K. B. (2021) · Biomolecules · doi:10.3390/biom11050681 · Cited by 54
Kciuk, M., Mujwar, S., Szymanowska, A., Marciniak, B., Bukowski, K., Mojzych, M., & Kontek, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115892 · Cited by 52
Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015–2021)
Olekšák, P., Nepovimová, E., Chrienová, Ž., Musílek, K., Patočka, J., & Kuča, K. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114498 · Cited by 53
Taurine from tumour niche drives glycolysis to promote leukaemogenesis
Sharma, S., Rodems, B. J., Baker, C. D., Kaszuba, C. M., Franco, E. I., Smith, B. R., Ito, T., Swovick, K., Welle, K. A., Zhang, Y., et al. (2025) · Nature · doi:10.1038/s41586-025-09018-7 · Cited by 53
Baicalein and Baicalin Promote Melanoma Apoptosis and Senescence via Metabolic Inhibition
Huang, L., Peng, B., Nayak, Y. R., Wang, C., Si, F., Liu, X., Dou, J., Xu, H., & Peng, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00836 · Cited by 51
The TSC Complex-mTORC1 Axis: From Lysosomes to Stress Granules and Back
Rehbein, U., Prentzell, M. T., Sandoval, M. C., Heberle, A. M., Henske, E. P., Opitz, C. A., & Thedieck, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.751892 · Cited by 52
Does Ras Activate Raf and PI3K Allosterically?
Nussinov, R., Tsai, C., & Jang, H. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01231 · Cited by 55
Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
Evangelisti, C., Chiarini, F., McCubrey, J. A., & Martelli, A. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071878 · Cited by 49
Ceska, T., Chung, C., Cooke, R., Phillips, C., & Williams, P. A. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180267 · Cited by 50
Insulin Regulation of Hepatic Lipid Homeostasis
Uehara, K., Santoleri, D., Whitlock, A. E. G., & Titchenell, P. M. (2023) · Comprehensive Physiology · doi:10.1002/cphy.c220015 · Cited by 49
Comparative evaluation of methods for the prediction of protein–ligand binding sites
Utgés, J. S., & Barton, G. J. (2024) · Journal of Cheminformatics · doi:10.1186/s13321-024-00923-z · Cited by 51
Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
Hage, A., & Dormond, O. (2021) · Cancers · doi:10.3390/cancers13061359 · Cited by 51
Yang, M., Hu, M. X., Zhang, Y., Jia, S., Sun, X., Zhao, W., Ge, M., & Dong, B. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03617-z · Cited by 50
Dinotefuran exposure induces autophagy and apoptosis through oxidative stress in Bombyx mori
Lu, Q., Xu, S., Hao, Z., Li, Y., Huang, Y., Ying, S., Jing, W., Zou, S., Xu, Y., & Wang, H. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.131997 · Cited by 48
Metadata
- Authors
- Yang, H., Jiang, X., Li, B., Yang, H. J., Miller, M., Yang, A., Dhar, A., & Pavletich, N. P.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Pavletich, Nikola P.
- Venue
- Nature
- Published
- 2017-12
- Volume
- 552
- Issue
- 7685
- Pages
- 368-373
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5750076
- OpenAlex
- W2773300145
- Cited by
- 548
- References
- 55
- Citations by year
- 2026: 55 · 2025: 65 · 2024: 68 · 2023: 66 · 2022: 63 · 2021: 80 · 2020: 74 · 2019: 53 · 2018: 23
- FWCI
- 16.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Memorial Sloan-Kettering Cancer Center (CA008748)
- National Institutes of Health (CA008748)
- National Cancer Institute (P30CA008748)
- National Institute of General Medical Sciences (P41GM103310, R01GM064644)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- mTORC1, Rheb, PRAS40, allosteric activation, allosteric inhibition, raptors, substrate recognition, cancer-associated mutations, mTOR hyperactivation, protein complex structure, cell growth regulation
- MeSH terms
- Protein Domains, Ras Homolog Enriched in Brain Protein, Mechanistic Target of Rapamycin Complex 1, Regulatory-Associated Protein of mTOR, Binding Sites, Enzyme Activation, Humans, Models, Molecular, Mutation, Neoplasms, Protein Binding, Substrate Specificity, Signal Transduction, Crystallography, X-Ray, Sirolimus, Catalytic Domain, Cryoelectron Microscopy, Amino Acid Motifs, Tacrolimus Binding Protein 1A, Ribosomal Protein S6 Kinases, 70-kDa, Adaptor Proteins, Signal Transducing, Biocatalysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
